QuickStats

Split Viewer

Public Health Weekly Report 2025; 18(10): 478-479

Published online March 13, 2025

https://doi.org/10.56786/PHWR.2025.18.10.3

© The Korea Disease Control and Prevention Agency

Trends in Prevalence of Chronic Kidney Disease, 2013–2023

Yoonjung Kim

Division of Health and Nutrition Survey and Analysis, Department of Chronic Disease Prevention and Control, Korea Disease Control and Prevention Agency

This is an Open Access aritcle distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted distribution, and reproduction in any medium, provided the original work is properly cited.

The age-standardized prevalence of chrinic kidney disease (CKD) in Korean adults aged ≥19 years was 5.5% in 2023, which was similar to the prevalence of 5.8% in 2022 (Figure 1). In 2023, the prevalence of CKD was observed to be associated with age; the prevalence was 25.1% in people aged ≥70 years (Figure 2).

Figure 1. Trends in prevalence of chronic kidney disease, 2013–2023

Figure 2. Prevalence of chronic kidney disease by age group, 2023

*Chronic kidney disease: glomerular filtration rate (CKD-EPI equation) ≥60 ml/min/1.73 m2 and urine albumin/creatinine ratio ≥30 mg/g, or glomerular filtration rate <60 ml/min/1.73 m2 among those aged ≥19 years.

**CKD-EPI: chronic kidney disease-epidemiology collaboration.

Results from 2015 to 2018 are not shown due to the absence of albuminuria.

Age-standardized prevalence was calculated using the 2005 population projections for Korea.

Source: Korea Health Statistics 2023, Korea National Health and Nutrition Examination Survey, https://knhanes.kdca.go.kr/

Reported by: Yoonjung Kim, Division of Health and Nutrition Survey and Analysis, Department of Chronic Disease Prevention and Control, Korea Disease Control and Prevention Agency

QuickStats

Public Health Weekly Report 2025; 18(10): 478-479

Published online March 13, 2025 https://doi.org/10.56786/PHWR.2025.18.10.3

Copyright © The Korea Disease Control and Prevention Agency.

Trends in Prevalence of Chronic Kidney Disease, 2013–2023

Yoonjung Kim

Division of Health and Nutrition Survey and Analysis, Department of Chronic Disease Prevention and Control, Korea Disease Control and Prevention Agency

This is an Open Access aritcle distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted distribution, and reproduction in any medium, provided the original work is properly cited.

Body

The age-standardized prevalence of chrinic kidney disease (CKD) in Korean adults aged ≥19 years was 5.5% in 2023, which was similar to the prevalence of 5.8% in 2022 (Figure 1). In 2023, the prevalence of CKD was observed to be associated with age; the prevalence was 25.1% in people aged ≥70 years (Figure 2).

Figure 1. Trends in prevalence of chronic kidney disease, 2013–2023

Figure 2. Prevalence of chronic kidney disease by age group, 2023

*Chronic kidney disease: glomerular filtration rate (CKD-EPI equation) ≥60 ml/min/1.73 m2 and urine albumin/creatinine ratio ≥30 mg/g, or glomerular filtration rate <60 ml/min/1.73 m2 among those aged ≥19 years.

**CKD-EPI: chronic kidney disease-epidemiology collaboration.

Results from 2015 to 2018 are not shown due to the absence of albuminuria.

Age-standardized prevalence was calculated using the 2005 population projections for Korea.

Source: Korea Health Statistics 2023, Korea National Health and Nutrition Examination Survey, https://knhanes.kdca.go.kr/

Reported by: Yoonjung Kim, Division of Health and Nutrition Survey and Analysis, Department of Chronic Disease Prevention and Control, Korea Disease Control and Prevention Agency

Fig 1.

Figure 1.Trends in prevalence of chronic kidney disease, 2013–2023
Public Health Weekly Report 2025; 18: 478-479https://doi.org/10.56786/PHWR.2025.18.10.3

Fig 2.

Figure 2.Prevalence of chronic kidney disease by age group, 2023
Public Health Weekly Report 2025; 18: 478-479https://doi.org/10.56786/PHWR.2025.18.10.3

PHWR